There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...
Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...
Like many adults over 60, Tom, a patient advocate for GSK, was unfamiliar with respiratory ... provider or pharmacist about getting vaccinated against RSV. AREXVY (Respiratory Syncytial Virus Vaccine, ...
As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...
RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...
New data from GSK's phase III study evaluating a single dose of RSV vaccine Arexvy indicates protection over three RSV ...